GRAIL, Inc. (GRAL) compared with its closest peers (BDSX, BLLN, PSNL, FLGT, XGN). Peer set by Healthcare Services; 10 comparable companies. First-party data.
Biodesix, BillionToOne, Personalis, Fulgent Genetics, Exagen, Castle Biosciences, CareDx, Veracyte, American Shared Hospital Services and Caris Life Sciences share GRAIL's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| Biodesix, Inc. (BDSX) | $294.06M | -1.5 |
| BillionToOne, Inc. (BLLN) | $5.45B | 172.9 |
| Personalis, Inc. (PSNL) | $1.84B | -8.8 |
| Fulgent Genetics, Inc. (FLGT) | $548.38M | -13.3 |
| Exagen Inc. (XGN) | $183.49M | -6.6 |
| Castle Biosciences, Inc. (CSTL) | $1.07B | -46.9 |
| CareDx, Inc (CDNA) | $2.63B | 22.3 |
| Veracyte, Inc. (VCYT) | $3.52B | 30.7 |
| American Shared Hospital Services (AMS) | $9.74M | -9.1 |
| Caris Life Sciences, Inc. (CAI) | $7.91B | -8.4 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
GRAL overview · GRAL earnings · GRAL financials · GRAL KPIs · GRAL documents · GRAL ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.